FormulaFolio Investments LLC Takes $722,000 Position in Anthem, Inc. (NYSE:ANTM)


Share on StockTwits

FormulaFolio Investments LLC bought a new stake in Anthem, Inc. (NYSE:ANTM) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,248 shares of the company’s stock, valued at approximately $722,000.

Several other hedge funds and other institutional investors have also modified their holdings of ANTM. Norges Bank bought a new position in Anthem during the 4th quarter worth approximately $866,682,000. Newport Trust Co acquired a new stake in Anthem during the 4th quarter worth approximately $472,366,000. Nuveen Asset Management LLC raised its holdings in Anthem by 27.3% during the 4th quarter. Nuveen Asset Management LLC now owns 2,526,510 shares of the company’s stock worth $811,237,000 after buying an additional 541,603 shares during the period. Sanders Capital LLC raised its holdings in shares of Anthem by 12.4% in the fourth quarter. Sanders Capital LLC now owns 3,450,167 shares of the company’s stock valued at $1,190,490,000 after purchasing an additional 381,247 shares during the last quarter. Finally, Orbimed Advisors LLC acquired a new stake in shares of Anthem in the fourth quarter valued at approximately $99,698,000. 89.36% of the stock is currently owned by institutional investors.

In other news, EVP Peter D. Haytaian sold 59,500 shares of the company’s stock in a transaction that occurred on Monday, March 22nd. The stock was sold at an average price of $349.20, for a total value of $20,777,400.00. Following the completion of the transaction, the executive vice president now owns 59,544 shares of the company’s stock, valued at $20,792,764.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Ronald W. Penczek sold 2,068 shares of the company’s stock in a transaction that occurred on Friday, March 5th. The shares were sold at an average price of $333.94, for a total value of $690,587.92. Following the completion of the transaction, the chief accounting officer now directly owns 3,137 shares of the company’s stock, valued at approximately $1,047,569.78. The disclosure for this sale can be found here. Corporate insiders own 0.22% of the company’s stock.

A number of research firms have recently issued reports on ANTM. Mizuho lifted their price objective on shares of Anthem from $300.00 to $320.00 and gave the company a “neutral” rating in a report on Friday, December 18th. Credit Suisse Group lowered their target price on shares of Anthem from $389.00 to $382.00 and set an “outperform” rating on the stock in a report on Thursday, January 28th. Truist upgraded shares of Anthem from a “hold” rating to a “buy” rating and boosted their target price for the stock from $360.00 to $375.00 in a report on Thursday, March 4th. Zacks Investment Research downgraded shares of Anthem from a “hold” rating to a “sell” rating and set a $379.00 target price on the stock. in a report on Thursday, March 25th. Finally, Stephens lowered their target price on shares of Anthem from $350.00 to $340.00 and set an “overweight” rating on the stock in a report on Thursday, January 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $359.81.

Shares of NYSE ANTM opened at $352.19 on Thursday. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.56. The company has a market cap of $86.25 billion, a price-to-earnings ratio of 18.21, a PEG ratio of 0.92 and a beta of 1.00. Anthem, Inc. has a 12 month low of $226.41 and a 12 month high of $379.13. The stock has a 50-day moving average price of $334.15 and a two-hundred day moving average price of $311.87.

Anthem (NYSE:ANTM) last issued its earnings results on Tuesday, January 26th. The company reported $2.54 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.52 by $0.02. The firm had revenue of $31.50 billion during the quarter, compared to the consensus estimate of $30.83 billion. Anthem had a return on equity of 18.45% and a net margin of 4.22%. The business’s quarterly revenue was up 16.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.88 earnings per share. On average, sell-side analysts predict that Anthem, Inc. will post 22.44 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 25th. Stockholders of record on Wednesday, March 10th were paid a $0.95 dividend. This represents a $3.80 annualized dividend and a dividend yield of 1.08%. The ex-dividend date of this dividend was Tuesday, March 9th. Anthem’s dividend payout ratio is currently 23.25%.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

See Also: Cost of Equity For A Business, Investors

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.